Increased plasma tissue factor levels in acute myocardial infarction

Area of Science:

• Cardiovascular Medicine
• Hematology
• Biochemistry

Background:

• Tissue factor (TF) is a critical glycoprotein initiating the coagulation cascade.
• TF plays a significant role in regulating hemostasis and thrombosis.
• Understanding TF levels in cardiovascular events is crucial for assessing thrombotic risk.

Purpose of the Study:

• To investigate plasma tissue factor (TF) levels in patients experiencing acute myocardial infarction (AMI).
• To compare TF levels between AMI patients, stable exertional angina patients, and healthy controls.
• To explore the relationship between TF levels and different clinical presentations of AMI, including prodromal unstable angina.

Main Methods:

• Plasma TF levels were measured in 31 AMI patients (within 6 hours of symptom onset), 27 stable exertional angina patients, and 27 control subjects.
• Patients with AMI were further categorized based on the onset of infarction (sudden vs. prodromal unstable angina).
• TF levels were assessed during the acute phase and in the chronic phase (2 weeks post-admission) for comparison.

Main Results:

• Plasma TF levels were significantly higher in the AMI group compared to both stable angina and control groups.
• TF levels decreased from the acute to the chronic phase in AMI patients.
• Patients with AMI and prodromal unstable angina exhibited higher TF levels than those with sudden onset AMI.

Conclusions:

• Elevated plasma TF levels in AMI patients suggest heightened intravascular procoagulant activity.
• The increased TF levels in AMI patients with prodromal unstable angina may be linked to recurrent ischemia-reperfusion events.
• TF may serve as a biomarker for thrombotic activity in acute coronary syndromes.